These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage. Giménez-Roldán S; Tolosa E; Burguera JA; Chacón J; Liaño H; Forcadell F Clin Neuropharmacol; 1997 Feb; 20(1):67-76. PubMed ID: 9037575 [TBL] [Abstract][Full Text] [Related]
13. Increased ratio of carbidopa to levodopa in treatment of Parkinson's disease. Tourtellotte WW; Syndulko K; Potvin AR; Hirsch SB; Potvin JH Arch Neurol; 1980 Nov; 37(11):723-6. PubMed ID: 7436817 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Parkinson's disease with pergolide: a double-blind study. Ahlskog JE; Muenter MD Mayo Clin Proc; 1988 Oct; 63(10):969-78. PubMed ID: 3050300 [TBL] [Abstract][Full Text] [Related]
15. Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease. Merello M; Lees AJ; Webster R; Bovingdon M; Gordin A J Neurol Neurosurg Psychiatry; 1994 Feb; 57(2):186-9. PubMed ID: 8126502 [TBL] [Abstract][Full Text] [Related]
16. Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial. Hauser RA; Hsu A; Kell S; Espay AJ; Sethi K; Stacy M; Ondo W; O'Connell M; Gupta S; Lancet Neurol; 2013 Apr; 12(4):346-56. PubMed ID: 23485610 [TBL] [Abstract][Full Text] [Related]
17. Increased dosage of carbidopa in patients with Parkinson's disease receiving low doses of levodopa. A pilot study. Hoehn MM Arch Neurol; 1980 Mar; 37(3):146-9. PubMed ID: 7356419 [TBL] [Abstract][Full Text] [Related]
18. Does levodopa slow or hasten the rate of progression of Parkinson's disease? Fahn S; J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436 [TBL] [Abstract][Full Text] [Related]
19. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease. Olanow CW; Fahn S; Muenter M; Klawans H; Hurtig H; Stern M; Shoulson I; Kurlan R; Grimes JD; Jankovic J Mov Disord; 1994 Jan; 9(1):40-7. PubMed ID: 8139604 [TBL] [Abstract][Full Text] [Related]
20. Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group I. Kurth MC; Adler CH; Hilaire MS; Singer C; Waters C; LeWitt P; Chernik DA; Dorflinger EE; Yoo K Neurology; 1997 Jan; 48(1):81-7. PubMed ID: 9008498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]